Review



fas l  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Miltenyi Biotec fas l
    Fas L, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fa/CD178+Antibody%2C+anti-human%2C+REAfinity/pm42455847-67-65-67
    Average 93 stars, based on 5 article reviews
    fas l - by Bioz Stars, 2026-09
    93/100 stars

    Images

    Related Articles

    Staining:

    Article Title: A novel Vδ1 engager targeting CD19 enhances human Vδ1 γδ T cell responses against CLL and CD19+ hematological malignancies.
    Article Snippet: γδ T cells are associated with favorable outcomes in many cancers likely through a mechanism of stress-directed cytotoxicity and antitumor cytokine production.. Vδ1 γδ T cells are especially promising for immunotherapy due to their broad stress recognition and resistance to activation-induced cell death.. Here, we generate a CD19 engager incorporating a novel Vδ1 binding moiety as proof-of-concept for treating CD19 cancers, including Chronic Lymphocytic Leukemia (CLL).

    Flow Cytometry:

    Article Title: A novel Vδ1 engager targeting CD19 enhances human Vδ1 γδ T cell responses against CLL and CD19+ hematological malignancies.
    Article Snippet: γδ T cells are associated with favorable outcomes in many cancers likely through a mechanism of stress-directed cytotoxicity and antitumor cytokine production.. Vδ1 γδ T cells are especially promising for immunotherapy due to their broad stress recognition and resistance to activation-induced cell death.. Here, we generate a CD19 engager incorporating a novel Vδ1 binding moiety as proof-of-concept for treating CD19 cancers, including Chronic Lymphocytic Leukemia (CLL).

    Recombinase Polymerase Amplification:

    Article Title: Feeder-cell-free system for ex vivo production of natural killer cells from cord blood hematopoietic stem and progenitor cells
    Article Snippet: .. 89Y CD45 HI30 Fluidigm 3089003B 106Cd CD71 REA902 Miltenyi 130-124-327 110Cd CD159c (NKG2C) REA205 Miltenyi 130-122-278 111Cd CCR7 G043H7 Biolegend 353237 112Cd CD98 REA387 Miltenyi 130-122-289 114Cd CD3 UCHT1 Biolegend 300402 114Cd CD14 M5E2 Biolegend 301843 114Cd CD19 HIB19 Biolegend 302247 114Cd CD33 WM53 Biolegend 303419 116Cd Glut1 202915 R&D Biosystems MAB61418 141Pr CCR6 G034E3 Fluidigm 3141003A 142Nd CXCR1 (CD181) 8F1/CXCR1 Fluidigm 3142009B 143Nd CD159a (NKG2A) REA110 Miltenyi 130-122-329 144Nd CD69 FN50 Fluidigm 3144018C 145Nd CD16 3G8 Fluidigm 3145008B 146Nd CD8 RPA-T8 Fluidigm 3146001B 147Sm CXCR2 (CD182) 5E8/CXCR2 Fluidigm 3147010B 148Nd Fas-L REA1056 Miltenyi 130-126-491 149Sm CD56 NCAM16.2 Fluidigm 3149021B 150Nd KLRG1 REA261 Miltenyi 130-126-458 151Eu CX3CR1 K0124E1 Biolegend 355702 152Sm KIR2DS4 REA860 Miltenyi 130-122-328 153Eu CD62-L DREG-56 Fluidigm 3153004C 154Sm TRAIL/TNFSF10 #75402 R&D Biosystems MAB687 155Gd CD 279 (PD1) EH12.2H7 Fluidigm 3155009B 156Gd CD195 (CCR5) NP-6G4 Fluidigm 3156015A 158Gd CD27 L128 Fluidigm 3158010B 159Tb CD337 (NKp30) Z25 Fluidigm 3159017B 160Gd CD158a/h (KIR2DL1/S1) REA1010 Miltenyi 130-122-345 161Dy CD336 (NKp44) REA1163 Miltenyi 130-126-465 162Dy CD335 (NKp46) BAB281 Fluidigm 3162021B 163Dy CD183 (CXCR3) G025H7 Fluidigm 3163004B 164Dy CD161 191B9 Miltenyi 130-092-676 166Er CD314 (NKG2D) ON72 Fluidigm 3166016B 167Er CD158e (KIR3DL1) NKB.1 DX9 Fluidigm 3167013B 168Er CD199 (CCR9) L053E8 Fluidigm 3168011C 169Tm Tim-3 F38-2E2 Fluidigm 3169028B 170Er CD122 (IL-2Rβ) Tu27 Fluidigm 3170004B 171Yb CD226 (DNAM-1) DX11 Fluidigm 3171013B 172Yb CD38 HIT2 Fluidigm 3172007C 173Yb CD158b (KIR2DL2/L3) DX27 Fluidigm 3173010B 174Yb CD94 HP-3D9 Fluidigm 3174015B 175Lu CD184 (CXCR4) 12G5 Fluidigm 3175001B 176Yb CD57 HCD57 Fluidigm 3176019B 191Ir/193Ir Cell-IDTM Intercalator-Ir - Fluidigm 201192A 195Pt Cell-ID Cisplatin - Fluidigm 201064 209Bi TIGIT MBSA43 Fluidigm 3209013B Supplementary Table 2 - Mass cytometry antibody function panel. ..

    Mass Cytometry:

    Article Title: Feeder-cell-free system for ex vivo production of natural killer cells from cord blood hematopoietic stem and progenitor cells
    Article Snippet: .. 89Y CD45 HI30 Fluidigm 3089003B 106Cd CD71 REA902 Miltenyi 130-124-327 110Cd CD159c (NKG2C) REA205 Miltenyi 130-122-278 111Cd CCR7 G043H7 Biolegend 353237 112Cd CD98 REA387 Miltenyi 130-122-289 114Cd CD3 UCHT1 Biolegend 300402 114Cd CD14 M5E2 Biolegend 301843 114Cd CD19 HIB19 Biolegend 302247 114Cd CD33 WM53 Biolegend 303419 116Cd Glut1 202915 R&D Biosystems MAB61418 141Pr CCR6 G034E3 Fluidigm 3141003A 142Nd CXCR1 (CD181) 8F1/CXCR1 Fluidigm 3142009B 143Nd CD159a (NKG2A) REA110 Miltenyi 130-122-329 144Nd CD69 FN50 Fluidigm 3144018C 145Nd CD16 3G8 Fluidigm 3145008B 146Nd CD8 RPA-T8 Fluidigm 3146001B 147Sm CXCR2 (CD182) 5E8/CXCR2 Fluidigm 3147010B 148Nd Fas-L REA1056 Miltenyi 130-126-491 149Sm CD56 NCAM16.2 Fluidigm 3149021B 150Nd KLRG1 REA261 Miltenyi 130-126-458 151Eu CX3CR1 K0124E1 Biolegend 355702 152Sm KIR2DS4 REA860 Miltenyi 130-122-328 153Eu CD62-L DREG-56 Fluidigm 3153004C 154Sm TRAIL/TNFSF10 #75402 R&D Biosystems MAB687 155Gd CD 279 (PD1) EH12.2H7 Fluidigm 3155009B 156Gd CD195 (CCR5) NP-6G4 Fluidigm 3156015A 158Gd CD27 L128 Fluidigm 3158010B 159Tb CD337 (NKp30) Z25 Fluidigm 3159017B 160Gd CD158a/h (KIR2DL1/S1) REA1010 Miltenyi 130-122-345 161Dy CD336 (NKp44) REA1163 Miltenyi 130-126-465 162Dy CD335 (NKp46) BAB281 Fluidigm 3162021B 163Dy CD183 (CXCR3) G025H7 Fluidigm 3163004B 164Dy CD161 191B9 Miltenyi 130-092-676 166Er CD314 (NKG2D) ON72 Fluidigm 3166016B 167Er CD158e (KIR3DL1) NKB.1 DX9 Fluidigm 3167013B 168Er CD199 (CCR9) L053E8 Fluidigm 3168011C 169Tm Tim-3 F38-2E2 Fluidigm 3169028B 170Er CD122 (IL-2Rβ) Tu27 Fluidigm 3170004B 171Yb CD226 (DNAM-1) DX11 Fluidigm 3171013B 172Yb CD38 HIT2 Fluidigm 3172007C 173Yb CD158b (KIR2DL2/L3) DX27 Fluidigm 3173010B 174Yb CD94 HP-3D9 Fluidigm 3174015B 175Lu CD184 (CXCR4) 12G5 Fluidigm 3175001B 176Yb CD57 HCD57 Fluidigm 3176019B 191Ir/193Ir Cell-IDTM Intercalator-Ir - Fluidigm 201192A 195Pt Cell-ID Cisplatin - Fluidigm 201064 209Bi TIGIT MBSA43 Fluidigm 3209013B Supplementary Table 2 - Mass cytometry antibody function panel. ..



    Similar Products

    fas l  (Miltenyi Biotec)
    93
    Miltenyi Biotec fas l
    Fas L, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fa/CD178+Antibody%2C+anti-human%2C+REAfinity/pm42455847-67-65-67
    Average 93 stars, based on 1 article reviews
    fas l - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    fas inhibitor met 12  (MedChemExpress)
    94
    MedChemExpress fas inhibitor met 12
    The effect of fisetin (10 and 20 µM) on Jurkat cell survival, measured using XTT assay. In the presence and absence of Fas receptor inhibitor <t>Met-12.</t> Data represented as mean ± SEM ( n = 3) Statistical analysis carried out using ANOVA followed by Tukey’s post hoc test for significance (* p < 0.05) (*** p < 0.001) (**** p < 0.0001).
    Fas Inhibitor Met 12, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fa/Met-12/pmc13300158-298-5-13
    Average 94 stars, based on 1 article reviews
    fas inhibitor met 12 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    cd95  (Miltenyi Biotec)
    93
    Miltenyi Biotec cd95
    The effect of fisetin (10 and 20 µM) on Jurkat cell survival, measured using XTT assay. In the presence and absence of Fas receptor inhibitor <t>Met-12.</t> Data represented as mean ± SEM ( n = 3) Statistical analysis carried out using ANOVA followed by Tukey’s post hoc test for significance (* p < 0.05) (*** p < 0.001) (**** p < 0.0001).
    Cd95, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fa/CD95+(FAS)+Antibody%2C+anti-human%2C+REAfinity/pm42380677-333-43-44
    Average 93 stars, based on 1 article reviews
    cd95 - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    cd95 (fas) antibody, anti-human  (Miltenyi Biotec)
    93
    Miltenyi Biotec cd95 (fas) antibody, anti-human
    The effect of fisetin (10 and 20 µM) on Jurkat cell survival, measured using XTT assay. In the presence and absence of Fas receptor inhibitor <t>Met-12.</t> Data represented as mean ± SEM ( n = 3) Statistical analysis carried out using ANOVA followed by Tukey’s post hoc test for significance (* p < 0.05) (*** p < 0.001) (**** p < 0.0001).
    Cd95 (Fas) Antibody, Anti Human, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fa/CD95+(FAS)+Antibody%2C+anti-human/custom%40130-124-261%4042323488
    Average 93 stars, based on 1 article reviews
    cd95 (fas) antibody, anti-human - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    centrifuge 5425 with rotor fa 24 × 2  (Eppendorf AG)
    96
    Eppendorf AG centrifuge 5425 with rotor fa 24 × 2
    The effect of fisetin (10 and 20 µM) on Jurkat cell survival, measured using XTT assay. In the presence and absence of Fas receptor inhibitor <t>Met-12.</t> Data represented as mean ± SEM ( n = 3) Statistical analysis carried out using ANOVA followed by Tukey’s post hoc test for significance (* p < 0.05) (*** p < 0.001) (**** p < 0.0001).
    Centrifuge 5425 With Rotor Fa 24 × 2, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fa/Rotor+FA-24x2/pmc13123351-24-0-6
    Average 96 stars, based on 1 article reviews
    centrifuge 5425 with rotor fa 24 × 2 - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    formic acid fa  (Fisher Scientific)
    86
    Fisher Scientific formic acid fa
    The effect of fisetin (10 and 20 µM) on Jurkat cell survival, measured using XTT assay. In the presence and absence of Fas receptor inhibitor <t>Met-12.</t> Data represented as mean ± SEM ( n = 3) Statistical analysis carried out using ANOVA followed by Tukey’s post hoc test for significance (* p < 0.05) (*** p < 0.001) (**** p < 0.0001).
    Formic Acid Fa, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fa/acid+formic/pm42319043-79-14-21
    Average 86 stars, based on 1 article reviews
    formic acid fa - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    gqds fa evo particle size  (Molecular Dynamics Inc)
    86
    Molecular Dynamics Inc gqds fa evo particle size
    The effect of fisetin (10 and 20 µM) on Jurkat cell survival, measured using XTT assay. In the presence and absence of Fas receptor inhibitor <t>Met-12.</t> Data represented as mean ± SEM ( n = 3) Statistical analysis carried out using ANOVA followed by Tukey’s post hoc test for significance (* p < 0.05) (*** p < 0.001) (**** p < 0.0001).
    Gqds Fa Evo Particle Size, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fa/evo+fa+gqds+particle+size/pm42309375-369-62-115
    Average 86 stars, based on 1 article reviews
    gqds fa evo particle size - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    hostastat fa 38  (Clariant Inc)
    86
    Clariant Inc hostastat fa 38
    The effect of fisetin (10 and 20 µM) on Jurkat cell survival, measured using XTT assay. In the presence and absence of Fas receptor inhibitor <t>Met-12.</t> Data represented as mean ± SEM ( n = 3) Statistical analysis carried out using ANOVA followed by Tukey’s post hoc test for significance (* p < 0.05) (*** p < 0.001) (**** p < 0.0001).
    Hostastat Fa 38, supplied by Clariant Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fa/38+fa+hostastat/us12654391-81-6-26
    Average 86 stars, based on 1 article reviews
    hostastat fa 38 - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    placcel fa series  (Daicel Corporation)
    86
    Daicel Corporation placcel fa series
    The effect of fisetin (10 and 20 µM) on Jurkat cell survival, measured using XTT assay. In the presence and absence of Fas receptor inhibitor <t>Met-12.</t> Data represented as mean ± SEM ( n = 3) Statistical analysis carried out using ANOVA followed by Tukey’s post hoc test for significance (* p < 0.05) (*** p < 0.001) (**** p < 0.0001).
    Placcel Fa Series, supplied by Daicel Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fa/fa+placcel+series/us12655307-82-20-25
    Average 86 stars, based on 1 article reviews
    placcel fa series - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    The effect of fisetin (10 and 20 µM) on Jurkat cell survival, measured using XTT assay. In the presence and absence of Fas receptor inhibitor Met-12. Data represented as mean ± SEM ( n = 3) Statistical analysis carried out using ANOVA followed by Tukey’s post hoc test for significance (* p < 0.05) (*** p < 0.001) (**** p < 0.0001).

    Journal: International Journal of Molecular Sciences

    Article Title: Synergistic Induction of Caspase-8-Mediated Leukaemic Cell Death by Fisetin and Pinocembrin

    doi: 10.3390/ijms27125622

    Figure Lengend Snippet: The effect of fisetin (10 and 20 µM) on Jurkat cell survival, measured using XTT assay. In the presence and absence of Fas receptor inhibitor Met-12. Data represented as mean ± SEM ( n = 3) Statistical analysis carried out using ANOVA followed by Tukey’s post hoc test for significance (* p < 0.05) (*** p < 0.001) (**** p < 0.0001).

    Article Snippet: Cells were treated with the Fas inhibitor Met-12 (CAS No. 1242964-46-0, purchased from MedChemExpress, catalogue number HY-P6440) at concentration of 20 μM and fisetin at concentrations of 10 μM and 20 μM, and combination treatments consisting of MET + fisetin (20 + 10 μM and 20 μM + 20 μM).

    Techniques: XTT Assay